ACPN Gives Edo Chairman 24 Hours To Prove Camosunate Ban
Posted on November 18, 2026
KINGSLEY EBERE

The Association of Community Pharmacists of Nigeria (ACPN) has issued a 24-hour ultimatum to the Chairman of the Edo State Consumer Protection Committee, Mr Osaro Culture Iyamu, to back up his claim that Camosunate is banned in Nigeria.
In a statement released by its national leadership, ACPN warned that Iyamu risks legal action if he fails to produce credible proof within the deadline.
The pharmacists’ body accused the Edo committee of overstepping its powers, making unverified drug claims and carrying out questionable enforcement under Iyamu’s watch.
ACPN said while it fully supports the fight against fake, expired and substandard medicines, such operations must be driven by evidence, expertise and respect for the law.
The bone of contention is Iyamu’s alleged public pronouncement that Camosunate, a well-known antimalarial, has been banned in the country.
ACPN described the claim as false and misleading.
To counter it, the Association said it checked NAFDAC’s official Greenbook and found Camosunate Children Powder listed as a duly registered medicine.
The product, according to ACPN, carries Registration Number 04-7908. It is manufactured by Front Pharmaceuticals PLC and marketed by Geneith Pharmaceuticals Limited.
Its registration, the Association said, was approved on November 26, 2025 and will remain valid till November 25, 2030.
ACPN argued that the Greenbook entry is an official regulatory record and not mere industry talk.
It therefore challenged Iyamu to, within 24 hours, present an authentic NAFDAC document showing prohibition, suspension, withdrawal or cancellation of that specific Camosunate formulation.
If he cannot, ACPN demanded that he immediately retract the claim in public and apologise.
The Association further warned that it will seek legal redress over any statement it finds to be false, harmful and without justification, especially where such statements affect registered medicines and licensed pharmacists.
ACPN also questioned the recent enforcement exercise at ALSO CARE Pharmacy in Evbuodia, along Airport Road, Benin City.
It asked the committee to publicly disclose the products allegedly seized, their registration status and the independent evidence relied upon to label them as counterfeit or banned.
According to the Association, no pharmacy should be subjected to public condemnation on the strength of unverified allegations.
On the legal angle, ACPN pointed to the Pharmacy Council of Nigeria (Establishment) Act 2022.
It said Sections 22, 31 and 32 of the Act clearly spell out how pharmaceutical premises are to be registered, inspected and enforced, through duly designated Pharmaceutical Inspection Officers.
The Association also cited Sections 7 and 8 of the Counterfeit and Fake Drugs and Unwholesome Processed Foods (Miscellaneous Provisions) Act, Cap C34, Laws of the Federation of Nigeria 2004, which govern the setting up and powers of State Task Forces.
ACPN contended that those statutory powers do not automatically belong to an ordinary State Consumer Protection Committee unless it can show it was properly constituted and its members duly appointed.
It equally referred to Section 5 of the NAFDAC Act, Cap N1, Laws of the Federation of Nigeria 2004, which vests the regulation of medicinal products in NAFDAC.
A general consumer protection mandate, ACPN argued, does not confer specialist powers to regulate pharmaceuticals.
Based on this, the Association listed six demands:
1. Immediate production of authentic NAFDAC documentation to prove the alleged Camosunate ban;
2. Public retraction and apology if the claim cannot be proved;
3. Disclosure by the Edo State Government of the legal instrument that established the committee;
4. Disclosure of any Federal Ministerial appointment or approval constituting the committee as a State Task Force under Section 7 of the Counterfeit and Fake Drugs Act;
5. An end to pharmaceutical enforcement without clear statutory authority; and
6. Respect for the regulatory roles of NAFDAC and the Pharmacy Council of Nigeria.
ACPN also appealed to the Edo State Governor, Senator Monday Okpebholo, to intervene urgently to restore institutional order and protect public confidence in the state’s healthcare system.
The Association insisted that consumer protection must not be turned into an excuse for misinformation, arbitrariness or intimidation of professionals.
It stressed that public officials must be held accountable for their public statements, that regulatory power must flow from the law, and that pharmacy practice must be protected within that same legal framework.
ACPN said it will pursue these principles through all legitimate institutional and legal avenues.
The statement was jointly signed by the ACPN National Chairman, Pharm. Ambrose Igwekamma Ezeh, MAW, and the National Secretary, Obigariel Ikwu.








